Paratek Pharmaceuticals logo
Paratek Pharmaceuticals PRTK
report update icon

Quarterly report 2023-Q2
added 05-23-2026

Paratek Pharmaceuticals Cash Conversion Cycle | PRTK

Annual Cash Conversion Cycle Paratek Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
252 1.41 K 658 486 54.5 181 4.69 K - 197 426 -62.3 2.67 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.69 K -62.3 754

Quarterly Cash Conversion Cycle Paratek Pharmaceuticals

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
269 309 - 176 113 278 73.6 242 129 457 67.7 656 636 744 86.2 907 1.58 K 1.57 K 0.22 74.8 93.5 23.2 K 90.7 38.3 K 61.2 12.8 K 362 - - - - - - - 101 2.22 K 1.38 K 4.45 K 63 - - -1.31 -5.74 - - - 1.03 - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
38.3 K -5.74 2.69 K

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
-816 - - $ 1.45 B britainBritain
KemPharm KemPharm
KMPH
-73.8 - -0.34 % $ 200 M usaUSA
Kezar Life Sciences Kezar Life Sciences
KZR
38.3 - - $ 53.3 M usaUSA
NovaBay Pharmaceuticals NovaBay Pharmaceuticals
NBY
28 - - $ 11.3 M usaUSA
OncoCyte Corporation OncoCyte Corporation
OCX
-224 - 17.22 % $ 355 K usaUSA
Onconova Therapeutics Onconova Therapeutics
ONTX
364 - -0.47 % $ 21 M usaUSA
Verastem Verastem
VSTM
-800 $ 9.17 5.04 % $ 636 M usaUSA
Plus Therapeutics Plus Therapeutics
PSTV
-336 M - - $ 301 M usaUSA
Pluristem Therapeutics Pluristem Therapeutics
PSTI
-508 - -1.9 % $ 33.3 M israelIsrael
Qualigen Therapeutics Qualigen Therapeutics
QLGN
49.8 - 5.59 % $ 1.16 M usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
111 - -6.08 % $ 184 M chinaChina
Sangamo Therapeutics Sangamo Therapeutics
SGMO
4.14 - - $ 50.4 M usaUSA
Salarius Pharmaceuticals Salarius Pharmaceuticals
SLRX
382 - - $ 2.64 M usaUSA
Sonnet BioTherapeutics Holdings Sonnet BioTherapeutics Holdings
SONN
-545 - - $ 826 K usaUSA
Vaxart Vaxart
VXRT
-5.69 - -25.06 % $ 46.3 M usaUSA
XOMA Corporation XOMA Corporation
XOMA
23.6 - - $ 485 M usaUSA
Sesen Bio Sesen Bio
SESN
391 - 7.29 % $ 127 M usaUSA
Windtree Therapeutics Windtree Therapeutics
WINT
-145 - - $ 26.8 M usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
25.5 - 57.95 % $ 12.8 M usaUSA
MEI Pharma MEI Pharma
MEIP
-36.8 - 10.43 % $ 20.5 M usaUSA
Palatin Technologies Palatin Technologies
PTN
6.22 - - $ 13 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Brickell Biotech Brickell Biotech
BBI
26 - -5.38 % $ 6.06 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
-4.37 K - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
18.6 - - $ 5.78 B niderlandNiderland
AbbVie AbbVie
ABBV
284 $ 294.72 0.32 % $ 521 B usaUSA